Skip to main content
Erschienen in: Endocrine 2/2020

05.05.2020 | Endocrine imaging

Periprostatic paraganglioma causing occult Cushing’s syndrome

verfasst von: Mojca Jensterle, Luka Lezaic, Jera Jeruc, Andrej Janez

Erschienen in: Endocrine | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Excerpt

A 25-year-old Caucasian male noticed the onset of poor concentration, depression, occasional paranoid feelings, loss of libido and insomnia. Over a 12-month period he gradually developed a Cushingoid appearance. At first examination he had low serum potassium 2.7 mmol/l (reference range, 3.8–5.5), an elevated midnight cortisol 2202 nmol/l (reference range, <50) and ACTH 34 pmol/l (reference range <10.2). High-dose dexamethasone suppression test and bilateral inferior petrosal sinus sampling with CRH stimulation were consistent with an ectopic Cushing syndrome (ECS) [1]. He started with metyrapone therapy. Ketoconazole was added several months later. Mean cortisol was maintained between 200 and 350 nmol/l, while ACTH level had increased on these medications, varying between 173 and 479 ng/l. …
Literatur
Metadaten
Titel
Periprostatic paraganglioma causing occult Cushing’s syndrome
verfasst von
Mojca Jensterle
Luka Lezaic
Jera Jeruc
Andrej Janez
Publikationsdatum
05.05.2020
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02335-z

Weitere Artikel der Ausgabe 2/2020

Endocrine 2/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.